(Stroke. 1999;30:1577-1582.)
© 1999 American Heart Association, Inc.
Original Contributions |
From the Division of Clinical Neuroscience (A.C.P.), CRC Biomedical Magnetic Resonance Research Group (V.L.D., F.A.H., J.R.G.), and Department of Public Health Medicine (J.M.B.), St George's Hospital Medical School; Department of Radiology (D.E.S.), King's College Hospital; and Institute of Neurology, University College (M.M.B.), London, UK.
Correspondence to Dr Anthony C. Pereira, c/o Prof Martin Brown, Institute of Neurology, Queen Square, London, WC1N 3BG, England. E-mail m.brown{at}ion.ucl.ac.uk
Background and Purpose1H MR spectroscopy can be used to study biochemical changes occurring in the brain in stroke. We used it to examine the relationship between metabolite concentration (N-acetyl aspartate [NAA], lactate, cholines and creatines), size of infarct, clinical deficit, and 3-month clinical outcome in patients with middle cerebral artery (MCA) territory infarction.
MethodsThirty-one patients with acute MCA territory infarction were recruited within 72 hours of the onset of symptoms. Single-voxel short echo time stimulated echo acquistion mode spectroscopy was used to obtain metabolite data from the infarct core. Metabolite concentrations were determined with use of variable projection time domain-fitting analysis. Infarct size was determined with T2-weighted images. Patient outcome groups at 3 months were "independent," "dependent," or "dead."
ResultsAll patients (100%; 95% CI 75% to 100%) who had an infarct >70 mL did poorly. Eighteen of 20 patients (90%; 95% CI 68% to 99%) with a core NAA concentration <7 mmol/L did poorly at 3 months, whereas 7 of 11 patients (64%; 95% CI 31% to 89%) with an initial NAA concentration >7 mmol/L did well. Combining these results showed that all patients who had an initial infarct volume >70 mL did poorly, irrespective of the NAA concentration. Of those patients with infarcts <70 mL, those who had a core NAA concentration >7 mmol/L did well (88%; 95% CI 47% to 100%), whereas those with a lower NAA concentration did poorly (80%; 95% CI 44% to 97%). There was no association between other metabolite concentrations and outcome.
ConclusionsInfarct volume and NAA concentration can together predict clinical outcome in MCA infarction in humans.
Key Words: human outcome spectroscopy, nuclear magnetic resonance stroke
This article has been cited by other articles:
![]() |
V. Cvoro, J. M. Wardlaw, I. Marshall, P. A. Armitage, C. S. Rivers, M. E. Bastin, T. K. Carpenter, K. Wartolowska, A. J. Farrall, and M. S. Dennis Associations Between Diffusion and Perfusion Parameters, N-Acetyl Aspartate, and Lactate in Acute Ischemic Stroke Stroke, March 1, 2009; 40(3): 767 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.L. Coon, F. Arias-Mendoza, G.P. Colby, J. Cruz-Lobo, J. Mocco, W.J. Mack, R.J. Komotar, T.R. Brown, and E.S. Connolly Jr. Correlation of Cerebral Metabolites with Functional Outcome in Experimental Primate Stroke Using in Vivo 1H-Magnetic Resonance Spectroscopy. AJNR Am. J. Neuroradiol., May 1, 2006; 27(5): 1053 - 1058. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Lindner, V. K. Gribkoff, N. A. Donlan, and T. A. Jones Long-Lasting Functional Disabilities in Middle-Aged Rats with Small Cerebral Infarcts J. Neurosci., November 26, 2003; 23(34): 10913 - 10922. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Oh, J.-G. Lee, S.-J. Na, J.-H. Park, Y.-C. Choi, and W.-J. Kim Prediction of Early Clinical Severity and Extent of Neuronal Damage in Anterior-Circulation Infarction Using the Initial Serum Neuron-Specific Enolase Level Arch Neurol, January 1, 2003; 60(1): 37 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Malloy Correlation of Cerebral Metabolites With Clinical Outcome Among Patients With Severe Congestive Heart Failure Circulation, June 12, 2001; 103(23): 2771 - 2772. [Full Text] [PDF] |
||||
![]() |
R. L. Levine One-Stop Shopping: Stroke Questions Further Answered With Magnetic Resonance Imaging Arch Neurol, April 1, 2001; 58(4): 555 - 556. [Full Text] [PDF] |
||||
![]() |
A C Pereira, P J Martin, and E A Warburton Thrombolysis in acute ischaemic stroke Postgrad. Med. J., March 1, 2001; 77(905): 166 - 171. [Full Text] |
||||
![]() |
C. J. M. Klijn, L. J. Kappelle, J. van der Grond, A. Algra, C. A. F. Tulleken, and J. van Gijn Magnetic Resonance Techniques for the Identification of Patients With Symptomatic Carotid Artery Occlusion at High Risk of Cerebral Ischemic Events Stroke, December 1, 2000; 31(12): 3001 - 3007. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. N. Thijs, M. G. Lansberg, C. Beaulieu, M. P. Marks, M. E. Moseley, and G. W. Albers Is Early Ischemic Lesion Volume on Diffusion-Weighted Imaging an Independent Predictor of Stroke Outcome? : A Multivariable Analysis Stroke, November 1, 2000; 31(11): 2597 - 2602. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Parsons, T. Li, P. A. Barber, Q. Yang, D. G. Darby, P. M. Desmond, R. P. Gerraty, B. M. Tress, and S. M. Davis Combined 1H MR spectroscopy and diffusion-weighted MRI improves the prediction of stroke outcome Neurology, August 22, 2000; 55(4): 498 - 506. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |